---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-078927"
form_type: "8-K"
ticker: "JSPR"
cik: "0001788028"
company_name: "Jasper Therapeutics, Inc."
filed_at: "2023-09-25T23:59:59+00:00"
generated_at: "2026-06-10T09:18:25.954319+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Jasper Therapeutics appoints Herb Cross as CFO; Jeet Mahal continues as COO

## Summary
- Herb Cross, age 51, appointed CFO and Corporate Secretary effective Sept 22, 2023; prior CFO at Atreca.
- Cross receives $460k base salary, 45% annual bonus target, $100k sign-on bonus.
- Granted option to purchase 550,000 shares at $0.78/share; vests over 4 years (25% cliff at 1 yr, then monthly).
- Jeet Mahal transitions from dual CFO/COO role to solely COO.
- Option is an inducement grant under Nasdaq Listing Rule 5635(c)(4).

## SEC filing metadata
- accession: 0001213900-23-078927
- form_type: 8-K
- ticker: JSPR
- cik: 0001788028
- company_name: Jasper Therapeutics, Inc.
- filed_at: 2023-09-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1788028/000121390023078927/0001213900-23-078927-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1788028/000121390023078927/ea185698-8k_jasper.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-078927
- JSON: https://secwatch.observer/filing/0001213900-23-078927.json
- Plain text: https://secwatch.observer/filing/0001213900-23-078927.txt

## Key facts
- Executive change
  Herb Cross was appointed as Chief Financial Officer and Corporate Secretary at Jasper Therapeutics, Inc..
  - Action: appointed
  - Role: Chief Financial Officer and Corporate Secretary
  source text: On September 21, 2023, the Board of Directors (the “Board”) of Jasper Therapeutics, Inc. (the “Company”) appointed Herb Cross, age 51 , as its Chief Financial Officer and Corporate Secretary.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1788028/000121390023078927/0001213900-23-078927-index.htm
- Executive change
  Jeet Mahal changed role as Chief Operating Officer at Jasper Therapeutics, Inc..
  - Action: transitioned to solely COO
  - Role: Chief Operating Officer
  source text: the Board approved the transition of Jeet Mahal, the Company’s Chief Financial Officer and Chief Operating Officer, to serve solely as the Company’s Chief Operating Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1788028/000121390023078927/0001213900-23-078927-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.